Inhibitor appears to strengthen anti-BCMA CAR T cells in myeloma patients

ORLANDO – All 10 patients responded to anti-BCMA CAR T-cell therapy, including 3 patients who had previously failed BCMA-directed therapy.

Read the full article here

Related Articles